Teleflex Launches "Never Settle" Brand Campaign at AVA Conference to Celebrate ARROW® Technologies a
Teleflex Launches "Never Settle" Brand Campaign at AVA Conference to Celebrate ARROW®Technologies and the Hard-Working Clinicians Who Use Them
New Teleflex advertisements celebrate ARROW vascular access products achievements and inspire clinicians to join the fight for zero complications
LIMERICK, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYS: TFX) , a leading global provider of medical devices for critical care and surgery, announces the launch of a new multi-media advertising campaign for its ARROW® brand. The "Never Settle" campaign applauds the dedication clinicians bring to their patients, while also conveying the company's commitment of working towards making zero complications a reality. The latest branding efforts will support product launches and communications for the ARROW® brand's comprehensive portfolio of vascular access products - products that improve patient safety by protecting against infection, thrombosis and malposition. Many of these innovations, like ARROW®VPS® Vascular Positioning System® and ARROW® PICC with Chlorag+ard® Technology, are featured at the annual Association for Vascular Access conference this week.
"Every day there are physicians and nurses who go beyond the call for their patients. They believe every patient should experience zero complications when treated with any vascular access product," says Paul Molloy, President, Vascular Division of Teleflex Incorporated. "That's why throughout our 35 year history, we have partnered with these clinicians to deliver vascular innovations that today protect against malposition, infection and thrombosis. Together, we are improving patient safety and overall care. That's what 'never settle' is all about."
ARROW-branded novel vascular access products will be on display throughout the week at AVA. The company is sponsoring three separate symposia, including two CE-accredited ones that highlight some of these advancements: "Breakthrough Research in Vascular Access" and "PICC Tip Positioning Technology - Inadvertent Arterial Cannulation."
Long Beach, California-based advertising agency, JLOOP Health, helped develop the new campaign and refers all inquiries to Teleflex. Additional information may be found at arrowintl.com.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, Pa, Teleflex employs approximately 11,200 people worldwide and serves healthcare providers in more than 130 countries. Additional information about Teleflex can be obtained from the company's website at teleflex.com.
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, ARROW, Chlorag+ard, Vascular Positioning System and VPSare registered trademarks of Teleflex Incorporated or its affiliates.
©2012 Teleflex Incorporated. All rights reserved. 2012-1466
Treasurer and Vice President, Investor Relations
KEYWORDS: United States North America Pennsylvania
The article Teleflex Launches "Never Settle" Brand Campaign at AVA Conference to Celebrate ARROW® Technologies and the Hard-Working Clinicians Who Use Them originally appeared on Fool.com.Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.